GLP1R and medullary thyroid gland carcinoma: This is in part because preclinical data show that GLP-1R agonists, including GLP-1 itself, can increase the proliferation of parafollicular C cells in the thyroid gland of rats, and in a C cell line derived from a rat medullary thyroid carcinoma (34, 35).